Last reviewed · How we verify

Oxybuprocaine MDU

Medical University of Vienna · Phase 3 active Small molecule

Oxybuprocaine MDU is a local anesthetic that works by blocking sodium channels in nerve fibers, preventing the initiation and transmission of nerve impulses.

Oxybuprocaine MDU is a local anesthetic that works by blocking sodium channels in nerve fibers, preventing the initiation and transmission of nerve impulses. Used for Corneal anesthesia.

At a glance

Generic nameOxybuprocaine MDU
SponsorMedical University of Vienna
Drug classLocal anesthetic
TargetSodium channels
ModalitySmall molecule
Therapeutic areaOphthalmology
PhasePhase 3

Mechanism of action

This action results in a temporary loss of sensation in the affected area, providing pain relief and reducing discomfort. Oxybuprocaine MDU is a derivative of cocaine, but with a more favorable safety profile.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results